QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors

AIM(S): Ciprofloxacin and fluconazole combination therapy is frequently used as prophylaxis for, and treatment of, infections in patients with haematological malignancies. However, both drugs are known to prolong the heart rate‐corrected QT (QTc) interval, which is a serious risk factor for torsade...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Clin Pharmacol
Autors principals: Berger, Florine A., Monadian, Nico, de Groot, Natasja M. S., Santbergen, Bart, van der Sijs, Heleen, Becker, Matthijs L., Broers, Annoek E. C., van Gelder, Teun, van den Bemt, Patricia M. L. A.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Drug Safety
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777440/
https://ncbi.nlm.nih.gov/pubmed/29057492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13457
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars